| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.00088 | 1 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.00083 | 1 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | 0.00077 | 1 |